Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: Relationships to blood serum levels and comedication

Epilepsy and Behavior

Volumn 5, Issue 5, 2004, Pages 716-721

  Kockelmann, Edgar ^a   Elger, Christian E ^a   Helmstaedter, Christoph ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Adverse effects; Blood serum level; Cognition; Topiramate

Indexed keywords

BENZODIAZEPINE; CARBAMAZEPINE; ETIRACETAM; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID; ANTICONVULSIVE AGENT; DRUG DERIVATIVE; FRUCTOSE; TRIAZINE DERIVATIVE;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; ATTENTION DEFICIT DISORDER; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; EPILEPSY; FEMALE; HUMAN; LANGUAGE DISABILITY; MAJOR CLINICAL STUDY; MALE; MEMORY CONSOLIDATION; MEMORY DISORDER; MOOD DISORDER; NEUROPSYCHOLOGICAL TEST; PHONEME; POLYPHARMACY; RETROSPECTIVE STUDY; SCORING SYSTEM; VERBAL COMMUNICATION; WORKING MEMORY; BLOOD; COGNITION; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; LANGUAGE; MEMORY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ADULT; ANTICONVULSANTS; COGNITION; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; FRUCTOSE; HUMANS; LANGUAGE; MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES; TRIAZINES; VALPROIC ACID;

EID: 15344345526     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yebeh.2004.06.017     Document Type: Article

References (35)

1. M. Angehagen E. Ben-Menachem L. Ronnback E. Hansson Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate Neurochem Res 28 2003 333-340
2. T.A. Glauser Topiramate Epilepsia 40 Suppl. 5 1999 71-80
3. T.W. May B. Rambeck U. Jurgens Serum concentrations of topiramate in patients with epilepsy: Influence of dose, age, and comedication Ther Drug Monit 24 2002 366-374
4. W.O. Tatum 4th J.A. French E. Faught et al. Postmarketing experience with topiramate and cognition Epilepsia 42 2001 1134-1140
5. M. Privitera R. Fincham J. Penry et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages Neurology 46 1996 1678-1683
6. R. Reife G. Pledger S.C. Wu Topiramate as add-on therapy: Pooled analysis of randomized controlled trials in adults Epilepsia 41 Suppl. 1 2000 S66-71
7. S.D. Shorvon Safety of topiramate: Adverse events and relationships to dosing Epilepsia 37 Suppl. 2 1996 S18-22
8. E. Faught B.J. Wilder R.E. Ramsay et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages Neurology 46 1996 1684-1690
9. A.P. Aldenkamp G. Baker O.G. Mulder et al. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures Epilepsia 41 2000 1167-1178
10. P.J. Thompson S.A. Baxendale J.S. Duncan J.W. Sander Effects of topiramate on cognitive function J Neurol Neurosurg Psychiatry 69 2000 636-641
11. H.J. Huppertz A. Quiske A. Schulze-Bonhage Cognitive impairments due to add-on therapy with topiramate Nervenarzt 72 2001 275-280
12. A. Guberman W. Neto C. Gassmann-Mayer et al. Low-dose topiramate in adults with treatment-resistant partial-onset seizures Acta Neurol Scand 106 2002 183-189
13. K.R. Edwards D.L. Potter S.C. Wu et al. Topiramate in the preventive treatment of episodic migraine: A combined analysis from pilot, double-blind, placebo-controlled trials CNS Spectr 8 2003 428-432
14. R. Martin R. Kuzniecky S. Ho et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults Neurology 52 1999 321-327
15. L.M. Ojemann G.A. Ojemann C.B. Dodrill C.A. Crawford M.D. Holmes D.L. Dudley Language disturbances as side effects of topiramate and zonisamide therapy Epilepsy Behav 2 2001 579-584
16. S. Lee V. Sziklas F. Andermann et al. The effects of adjunctive topiramate on cognitive function in patients with epilepsy Epilepsia 44 2003 339-347
17. E. Baeta I. Santana G. Castro et al. Cognitive effects of therapy with topiramate in patients with refractory partial epilepsy Rev Neurol 34 2002 737-741
18. L.A. Burton C. Harden Effect of topiramate on attention Epilepsy Res 27 1997 29-32
19. K.J. Meador F.G. Gilliam A.M. Kanner J.M. Pellock Cognitive and behavioral effects of antiepileptic drugs Epilepsy Behav 2 2001 SS1-17
20. F.G. Gilliam F. Veloso Tolerability of topiramate as monotherapy in patients with recently diagnosed partial epilepsy Epilepsia 39 Suppl. 6 1998 56
21. P. Kwan M.J. Brodie Neuropsychological effects of epilepsy and antiepileptic drugs Lancet 357 2001 216-222
22. Lehrl S. Mehrfachwahl-Wortschatz-Intelligenztest MWT-B. Verlag Dr. med. Straube; 1978
23. Beck AT, Rush AJ, Shaw BF, Emery G. Kognitive Therapie der Depression. Munich: Urban & Schwarzenberg; 1981
24. Cramer J. Quality of Life in Epilepsy Inventory: QOLIE-10. Quality of Life in Epilepsy-10, Professional Postgraduate Services; 1993
25. Lehrl S Fischer, B. c.I.-Test zur raschen Objektivierung cerebraler Insuffizienzen. Ebersberg: Vless; 1985
26. R.M. Reitan Trail Making Test: Manual for administration and scoring 1992 Neuropsychology Laboratory Tucson, AZ
27. Chapuis F. Sprachfreie Intelligenzbatterien und Einzeltests. Der Labyrinth-Test; Le Test Du Labyrinthe. Bern: Verlag Hans Huber; 1959
28. Brickenkamp R. Test d2 Aufmerksamkeits-Belastungs-Test. Göttingen: Hogrefe; 1978
29. Tewes U. Hamburg-Wechsler Intelligenztest für Erwachsene Revision. Bern: Verlag Hans Huber; 1991
30. P.M. Corsi Human memory and the medial temporal region of the brain Diss Abstr Int 34 1972 819B
31. W. Horn Leistungsprüfsystem L-P-S 1983 Verlag Hans Huber Bern
32. W. Huber K. Poeck D. Weniger K. Willmes Aachener Aphasie Test (AAT) 1983 Hogrefe Göttingen
33. C. Helmstaedter M. Lendt S. Lux VLMT: Verbaler Lern- und Merkfähigkeitstest, Testhandbuch 2000 Hogrefe Göttingen
34. Helmstaedter C, Pohl C, Elger CE. Eine modifizierte Version des Diagnostikums für Cerebralschäden (DCS) zur Diagnostik räumlich-visueller Gedächtnisdefizite bei Patienten mit Temporallappenepilepsie. In: Scheffner D, ed. Epilepsie 90. Reinbeck: Einhorn-Presse Verlag; 1991
35. E. Kockelmann C.E. Elger C. Helmstaedter Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients Epilepsy Res 54 2003 171-178